Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Christian Grommes, Elena Pentsova, Lauren R. Schaff, Craig P. Nolan, Thomas Kaley, Anne S. Reiner, Katherine S. Panageas & Ingo K. Mellinghoff. (2023) Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma. Leukemia & Lymphoma 64:9, pages 1545-1553.
Read now
Read now
Giovanni Citterio, Teresa Calimeri & Andrés J. M. Ferreri. (2018) Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma. Expert Review of Neurotherapeutics 18:5, pages 379-393.
Read now
Read now
Giovanni Citterio, Michele Reni & Andrés José Maria Ferreri. (2015) Present and future treatment options for primary CNS lymphoma. Expert Opinion on Pharmacotherapy 16:17, pages 2569-2579.
Read now
Read now
Saurabh Dahiya, Erin S Murphy, Samuel T Chao, Glen HJ Stevens, David M Peereboom & Manmeet S Ahluwalia. (2013) Recurrent or refractory primary central nervous lymphoma: therapeutic considerations. Expert Review of Anticancer Therapy 13:9, pages 1109-1119.
Read now
Read now
Matteo G Carrabba, Michele Reni, Marco Foppoli, Anna Chiara, Alberto Franzin, Letterio Salvatore Politi, Eugenio Villa, Fabio Ciceri & Andrés JM Ferreri. (2010) Treatment approaches for primary CNS lymphomas. Expert Opinion on Pharmacotherapy 11:8, pages 1263-1276.
Read now
Read now
Andrés J. M. Ferreri, Roberto Crocchiolo, Andrea Assanelli, Silvia Govi & Michele Reni. (2008) High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions. Leukemia & Lymphoma 49:11, pages 2042-2047.
Read now
Read now
Nancy D. Doolittle, Kristoph Jahnke, Richard Belanger, Deborah A. Ryan, Robert W. Nance$suffix/text()$suffix/text(), Cynthia A. Lacy, Rose Marie Tyson, Marianne Haluska, Nancy A. Hedrick, Csanad Varallyay & Edward A. Neuwelt. (2007) Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma. Leukemia & Lymphoma 48:9, pages 1712-1720.
Read now
Read now
Articles from other publishers (41)
Erica A. Power, Julian S. Rechberger, Sumit Gupta, Jonathan D. Schwartz, David J. Daniels & Soumen Khatua. (2022) Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update. Advanced Drug Delivery Reviews 185, pages 114303.
Crossref
Crossref
I. V. Cherkashina, M. A. Vernyuk, A. M. Chervontseva, E. E. Gushchina, L. S. Khayrullina, V. V. Lunin, P. A. Zeynalova & A. A. Fedenko. (2021) Treatment of primary central nervous system lymphomas. Oncohematology 16:2, pages 10-20.
Crossref
Crossref
Jessica I. Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R. Drewes, Jann N. Sarkaria & William F. Elmquist. (2020) Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics 12:12, pages 1205.
Crossref
Crossref
John M. McGregor, Nancy D. Doolittle, Emily Youngers, Susan D. Bell & Edward A. Neuwelt. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
193
208
.
Louis Royer-Perron & Khê Hoang-Xuan. (2018) Management of primary central nervous system lymphoma. La Presse Médicale 47:11-12, pages e213-e244.
Crossref
Crossref
John M. McGregor, Susan D. Bell, Nancy D. Doolittle, Tulio P. Murillo & Edward A. Neuwelt. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
145
153
.
Giovanni Citterio, Michele Reni, Gemma Gatta & Andrés José Maria Ferreri. (2017) Primary central nervous system lymphoma. Critical Reviews in Oncology/Hematology 113, pages 97-110.
Crossref
Crossref
Agnieszka KorfelUwe SchlegelDerek R. JohnsonTimothy J. KaufmannCaterina GianniniTakanori Hirose. (2017) Case-based review: primary central nervous system lymphoma. Neuro-Oncology Practice 4:1, pages 46-59.
Crossref
Crossref
Liren QianCiprian TomuleasaIoan-Alexandru FlorianJianliang ShenIoan-Stefan FlorianMihnea ZdrengheaDelia Dima. (2017) Advances in the treatment of newly diagnosed primary central nervous system lymphomas. Blood Research 52:3, pages 159.
Crossref
Crossref
Agnieszka KorfelUwe SchlegelUlrich HerrlingerMartin DreylingChristian SchmidtLuisa von BaumgartenAntonio PezzuttoThomas GroboschSied KebirEckhard ThielPeter MartusPhilipp Kiewe. (2016) Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma. Journal of Clinical Oncology 34:15, pages 1757-1763.
Crossref
Crossref
Xuexin Yu, Lin Feng, Dianming Liu, Lianfeng Zhang, Bo Wu, Wei Jiang, Zujing Han & Shujun Cheng. (2016) Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme. Oncotarget 7:12, pages 14161-14171.
Crossref
Crossref
Karl-Michael Schebesch, Julius Hoehne, Christoph Hohenberger, Francesco Acerbi, Morgan Broggi, Martin Proescholdt, Christina Wendl, Markus J. Riemenschneider & Alexander Brawanski. (2015) Fluorescein sodium-guided surgery in cerebral lymphoma. Clinical Neurology and Neurosurgery 139, pages 125-128.
Crossref
Crossref
Ravi Kumar, Nadia Laack, Bruce E. Pollock, Michael Link, Brian P. O’Neill & Ian F. Parney. (2015) Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. World Neurosurgery 84:2, pages 390-397.
Crossref
Crossref
Nancy D. Doolittle, Leslie L. Muldoon, Aliana Y. Culp & Edward A. Neuwelt. 2014. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders
203
243
.
Silvia Mappa, Emerenziana Marturano, Giada Licata, Maurizio Frezzato, Niccolò Frungillo, Fiorella Ilariucci, Caterina Stelitano, Antonella Ferrari, Mariella Sorarù, Fabrizio Vianello, Luca Baldini, Ilaria Proserpio, Marco Foppoli, Andrea Assanelli, Michele Reni, Federico Caligaris‐Cappio & Andrés J. M. Ferreri. (2012) Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R‐IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high‐dose methotrexate‐based chemotherapy. Hematological Oncology 31:3, pages 143-150.
Crossref
Crossref
Agnieszka Korfel & Uwe Schlegel. (2013) Diagnosis and treatment of primary CNS lymphoma. Nature Reviews Neurology 9:6, pages 317-327.
Crossref
Crossref
Prathima ProdduturiPhilip J Bierman. (2012) Current and Emerging Pharmacotherapies for Primary CNS Lymphoma. Clinical Medicine Insights: Oncology 6, pages CMO.S7752.
Crossref
Crossref
Andrés J. M. Ferreri. (2011) How I treat primary CNS lymphoma. Blood 118:3, pages 510-522.
Crossref
Crossref
Michele Reni, Elena Mazza & Andrés J. M. Ferreri. 2011. Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy, and Prognosis
337
351
.
Manmeet S. Ahluwalia & David M. Peereboom. (2010) Primary Central Nervous System Lymphoma. Current Treatment Options in Neurology 12:4, pages 347-359.
Crossref
Crossref
M. Sierra Del Rio, A. Rousseau, Carole Soussain & Hoang-Xuan Khe. 2010. Neuro-Oncology. Neuro-Oncology
201
217
.
János László Iványi, Éva Marton, Márk Plander, Gabriella Gyánó, László Czumbil & Csaba Tóth. (2009) Therapeutic management of central nervous system lymphomas in a single hematological institute. Orvosi Hetilap 150:42, pages 1937-1944.
Crossref
Crossref
Lilyana AngelovNancy D. DoolittleDale F. KraemerTali SiegalGene H. BarnettDavid M. PeereboomGlen StevensJohn McGregorKristoph JahnkeCynthia A. LacyNancy A. HedrickEdna ShalomSandra FerenceSusan BellLisa SorensonRose Marie TysonMarianne HaluskaEdward A. Neuwelt. (2009) Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience. Journal of Clinical Oncology 27:21, pages 3503-3509.
Crossref
Crossref
Patrick G Morris & Lauren E Abrey. (2009) Therapeutic challenges in primary CNS lymphoma. The Lancet Neurology 8:6, pages 581-592.
Crossref
Crossref
Monica Sierra del Rio, Audrey Rousseau, Carole Soussain, Damien Ricard & Khê Hoang-Xuan. (2009) Primary CNS Lymphoma in Immunocompetent Patients. The Oncologist 14:5, pages 526-539.
Crossref
Crossref
Carole SoussainKhê Hoang-XuanLuc TaillandierEmmanuelle FourmeSylvain ChoquetFrancis WitzOlivier CasasnovasBrigitte DupriezBertrand SouleauAnne-Laure TaksinChristian GisselbrechtArnaud JaccardAntonio OmuroMarc SansonMaud JanvierBrigitte KolbJean-Marc ZiniVéronique Leblond. (2008) Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. Journal of Clinical Oncology 26:15, pages 2512-2518.
Crossref
Crossref
Alfredo D. Voloschin, Rebecca Betensky, Patrick Y. Wen, Fred Hochberg & Tracy Batchelor. (2007) Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma. Journal of Neuro-Oncology 86:2, pages 211-215.
Crossref
Crossref
Michele Reni, Elena Mazza, Marco Foppoli & Andrés J.M. Ferreri. (2007) Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate. Cancer Letters 258:2, pages 165-170.
Crossref
Crossref
Andrés J.M. Ferreri & Michele Reni. (2007) Primary central nervous system lymphoma. Critical Reviews in Oncology/Hematology 63:3, pages 257-268.
Crossref
Crossref
Eric M. Bessell, Khe Hoang-Xuan, Andres J.M. Ferreri & Michele Reni. (2007) Primary central nervous system lymphoma – Biological aspects and controversies in management. European Journal of Cancer 43:7, pages 1141-1152.
Crossref
Crossref
M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R Bordonaro, F Ilariucci, M Faedi, G Corazzelli, P Manno, E Franceschi, A Pace, M Candela, A Abbadessa, C Stelitano, G Latte & A J M Ferreri. (2007) Temozolomide as salvage treatment in primary brain lymphomas. British Journal of Cancer 96:6, pages 864-867.
Crossref
Crossref
Matthew A. Hunt, Kristoph Jahnke, Tulio P. Murillo & Edward A. Neuwelt. (2006) Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches. Neurosurgical Focus 21:5, pages 1-7.
Crossref
Crossref
L. Fischer, E. Thiel, H.-A. Klasen, J. Birkmann, K. Jahnke, P. Martus & A. Korfel. (2006) Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Annals of Oncology 17:7, pages 1141-1145.
Crossref
Crossref
Masato Sakamoto, Natsuo Oya, Takashi Mizowaki, Norio Araki, Yasushi Nagata, Kenji Takayama, Jun A Takahashi, Hideyuki Kano, Takahisa Katsuki, Nobuo Hashimioto & Masahiro Hiraoka. (2005) Initial Experiences of Palliative Stereotactic Radiosurgery for Recurrent Brain Lymphomas. Journal of Neuro-Oncology 77:1, pages 53-58.
Crossref
Crossref
Nancy D. Doolittle, Tulio P. Murillo & Edward A. Neuwelt. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
262
273
.
Carole Soussain, Khê Hoang-Xuan & Nancy D. Doolittle. (2005) New Treatment Approaches in Primary Central Nervous System Lymphoma. Hematology/Oncology Clinics of North America 19:4, pages 719-728.
Crossref
Crossref
Khê Hoang-Xuan, Sophie Camilleri-Broët & Carole Soussain. (2004) Recent advances in primary CNS lymphoma. Current Opinion in Oncology 16:6, pages 601-606.
Crossref
Crossref
Michele Reni, Warren Mason, Francesco Zaja, James Perry, Enrico Franceschi, Daniele Bernardi, Stefania Dell'Oro, Caterina Stelitano, Marco Candela, Antonio Abbadessa, Andrea Pace, Roberto Bordonaro, Giancarlo Latte, Eugenio Villa & Andrés J.M Ferreri. (2004) Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. European Journal of Cancer 40:11, pages 1682-1688.
Crossref
Crossref
Marianne Haluska & Margaret L. Anthony. (2004) Osmotic Blood-Brain Barrier Modification for the Treatment of Malignant Brain Tumors. Clinical Journal of Oncology Nursing 8:3, pages 263-267.
Crossref
Crossref
Julette F Batara & Stuart A Grossman. (2003) Primary central nervous system lymphomas. Current Opinion in Neurology 16:6, pages 671-675.
Crossref
Crossref
Neta Goldschmidt, Eduard Linetsky, Edna Shalom, David Varon & Tali Siegal. (2003) High incidence of thromboembolism in patients with central nervous system lymphoma. Cancer 98:6, pages 1239-1242.
Crossref
Crossref